Kirsten M. Timms

11.8k total citations · 1 hit paper
96 papers, 4.6k citations indexed

About

Kirsten M. Timms is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Kirsten M. Timms has authored 96 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 59 papers in Molecular Biology and 41 papers in Genetics. Recurrent topics in Kirsten M. Timms's work include PARP inhibition in cancer therapy (52 papers), DNA Repair Mechanisms (43 papers) and BRCA gene mutations in cancer (33 papers). Kirsten M. Timms is often cited by papers focused on PARP inhibition in cancer therapy (52 papers), DNA Repair Mechanisms (43 papers) and BRCA gene mutations in cancer (33 papers). Kirsten M. Timms collaborates with scholars based in United States, United Kingdom and Germany. Kirsten M. Timms's co-authors include Jerry S. Lanchbury, Alexander Gutin, Jennifer Potter, Gordon B. Mills, Bryan T. Hennessy, Victor Abkevich, Srikanth Jammulapati, Mark Carey, Diana Iliev and Julia Reid and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Kirsten M. Timms

95 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

2012 494 citations Victor Abkevich, Kirsten M. Timms et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirsten M. Timms United States	27	2.6k	2.2k	1.5k	1.2k	681	96	4.6k
Niklas Loman Sweden	27	3.4k 1.3×	2.6k 1.2×	2.2k 1.5×	1.7k 1.4×	999 1.5×	52	5.8k
Lora H. Ellenson United States	34	1.2k 0.5×	3.0k 1.4×	669 0.5×	1.1k 0.9×	1.6k 2.4×	108	5.5k
Ingunn M. Stefansson Norway	36	1.5k 0.6×	2.2k 1.0×	470 0.3×	1.3k 1.1×	625 0.9×	73	4.4k
Evgeny N. Imyanitov Russia	31	1.4k 0.6×	2.2k 1.0×	1.1k 0.7×	1.2k 1.0×	249 0.4×	278	4.1k
Patricia N. Tonin Canada	37	1.2k 0.5×	2.7k 1.2×	1.7k 1.2×	1.0k 0.9×	801 1.2×	127	4.5k
John I. Risinger United States	41	1.6k 0.6×	3.2k 1.5×	850 0.6×	1.7k 1.5×	915 1.3×	94	5.8k
Sílvia Menéndez United States	32	1.2k 0.5×	2.5k 1.2×	393 0.3×	903 0.8×	389 0.6×	76	4.0k
Heli Nevanlinna Finland	43	1.7k 0.7×	3.1k 1.4×	2.3k 1.5×	1.5k 1.3×	260 0.4×	124	5.2k
M. William Audeh United States	16	4.1k 1.6×	2.7k 1.2×	1.6k 1.0×	1.2k 1.0×	998 1.5×	35	5.2k
Rita K. Schmutzler Germany	22	2.7k 1.1×	2.5k 1.1×	1.3k 0.9×	917 0.8×	488 0.7×	49	4.1k

Countries citing papers authored by Kirsten M. Timms

Since Specialization

Citations

This map shows the geographic impact of Kirsten M. Timms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten M. Timms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten M. Timms more than expected).

Fields of papers citing papers by Kirsten M. Timms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten M. Timms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten M. Timms. The network helps show where Kirsten M. Timms may publish in the future.

Co-authorship network of co-authors of Kirsten M. Timms

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten M. Timms. A scholar is included among the top collaborators of Kirsten M. Timms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten M. Timms. Kirsten M. Timms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hattesohl, Akira, Julia Teply‐Szymanski, Florian Heitz, et al.. (2024). Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer—Development of Recommendations for Optimal Assay Performance. Modern Pathology. 37(4). 100445–100445. 5 indexed citations

Whitaker, Regina S., Shonagh Russell, Benjamin B. Albright, et al.. (2023). Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma. Cancers. 15(2). 528–528. 1 indexed citations

Lotan, Tamara L., Harsimar Kaur, Daniela C. Salles, et al.. (2021). Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Modern Pathology. 34(6). 1185–1193. 67 indexed citations

Kaur, Harsimar, Daniela C. Salles, Sanjana Murali, et al.. (2020). Genomic and Clinicopathologic Characterization of ATM -deficient Prostate Cancer. Clinical Cancer Research. 26(18). 4869–4881. 25 indexed citations

Telli, Melinda L., Charles C. Chu, Sunil Badve, et al.. (2019). Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis. Clinical Cancer Research. 26(11). 2704–2710. 23 indexed citations

Stronach, Euan A., James Paul, Kirsten M. Timms, et al.. (2018). Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy. Molecular Cancer Research. 16(7). 1103–1111. 81 indexed citations

Hodgson, Darren, Brian Dougherty, Zhongwu Lai, et al.. (2018). Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. British Journal of Cancer. 119(11). 1401–1409. 167 indexed citations

Afghahi, Anosheh, Kirsten M. Timms, Shaveta Vinayak, et al.. (2017). Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance. Clinical Cancer Research. 23(13). 3365–3370. 55 indexed citations

Timms, Kirsten M., Anees B. Chagpar, Vikram B. Wali, et al.. (2016). Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer. Clinical Cancer Research. 23(5). 1193–1199. 26 indexed citations

10.

Lanchbury, Jerry S., Kirsten M. Timms, Euan A. Stronach, et al.. (2016). 3-biomarker HRD score versus individual biomarker (LOH, TAI, LST) scores in platinum treated serous ovarian cancer (SOC). Annals of Oncology. 27. vi34–vi34. 3 indexed citations

11.

Déas, Olivier, Stefano Cairo, Keith Wilcoxen, et al.. (2016). Abstract 4353: Preclinical evaluation of the PARP inhibitor niraparib and cytotoxic chemotherapy alone or in combination in a panel of 25 triple-negative breast cancer PDX models: Relevance of BRCA mutations, HRD status and other biomarkers. Cancer Research. 76(14_Supplement). 4353–4353. 2 indexed citations

12.

Timms, Kirsten M., Victor Abkevich, Elisha Hughes, et al.. (2014). Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes. Breast Cancer Research. 16(6). 475–475. 273 indexed citations

13.

Stordal, Britta, Kirsten M. Timms, Angela M. Farrelly, et al.. (2013). BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation. Molecular Oncology. 7(3). 567–579. 116 indexed citations

14.

Capon, Francesca, Marie-José Bijlmakers, Maria Quaranta, et al.. (2008). Characterization of ZNF313/RNF114 as a novel psoriasis susceptibility gene. British Journal of Dermatology. 159(6). 1389–1389. 1 indexed citations

15.

Guirguis, Alfred, Esther Elishaev, Kirsten M. Timms, et al.. (2007). Characterization of concurrent ovarian and endometrial carcinoma by copy-number analysis (CNA) and gene expression profiling (GEP). Journal of Clinical Oncology. 25(18_suppl). 10546–10546.

16.

Valdes, Ana M., Kirsten M. Timms, Ayrun Nessa, et al.. (2007). 17 GENOME-WIDE ASSOCIATION SCAN OF OSTEOARTHRITIS OF THE KNEE. Osteoarthritis and Cartilage. 15. C24–C24. 1 indexed citations

17.

Adamski, Frances M., Kirsten M. Timms, & Bih‐Hwa Shieh. (1999). A unique isoform of phospholipase Cβ4 highly expressed in the cerebellum and eye. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1444(1). 55–60. 25 indexed citations

18.

Timms, Kirsten M., M. Ali Ansari‐Lari, Wendy L. Morris, Stephen Brown, & Richard A. Gibbs. (1998). The genomic organization of Isopeptidase T-3 (ISOT-3), a new member of the ubiquitin specific protease family (UBP). Gene. 217(1-2). 101–106. 20 indexed citations

19.

Timms, Kirsten M., Marie-Louise Bondeson, M. Ali Ansari‐Lari, et al.. (1996). Phenotypic variation in patients with severe Hunter syndrome. The American Journal of Human Genetics. 59. 210. 1 indexed citations

20.

Timms, Kirsten M., Fei Lü, Ying H. Shen, et al.. (1995). 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus.. Genome Research. 5(1). 71–78. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact